Mibashan et al., 1980 - Google Patents
Dual diagnosis of prenatal haemophilia A by measurement of fetal factor VIIIC and VIIIC antigen (VIIICAg)Mibashan et al., 1980
- Document ID
- 11588622172992970107
- Author
- Mibashan R
- Rodeck C
- Furlong R
- Bains L
- Peake I
- Thumpston J
- Gorer R
- Bloom A
- Publication year
- Publication venue
- The Lancet
External Links
Snippet
Procoagulant factor VIII (VIIIC) and procoagulant factor VIII antigen (VIIICAg) were measured in 20 samples of pure fetal blood obtained by fetoscopy at mid-term from non-hæmophilic fetuses. VIIIC levels ranged from 25 to 89 U/dl (mean 43· 5) and VIIICAg from 11 to 43 U/dl …
- 101710041060 COX7A1 0 title abstract description 36
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
- A61B10/0045—Devices for taking samples of body liquids
- A61B10/007—Devices for taking samples of body liquids for taking urine samples
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Mibashan et al. | Dual diagnosis of prenatal haemophilia A by measurement of fetal factor VIIIC and VIIIC antigen (VIIICAg) | |
| Mibashan et al. | Plasma assay of fetal factors VIIIC and IX for prenatal diagnosis of haemophilia | |
| Petit et al. | Detection of maternal cells in human fetal blood during the third trimester of pregnancy using allele‐specific PCR amplification | |
| BRODY et al. | Immuno-assay of human chorionic gonadotropin in normal and pathologic pregnancy | |
| Oksenberg et al. | Mixed lymphocyte reactivity nonresponsiveness in couples with multiple spontaneous abortions. | |
| Pacsa et al. | Impairment of immunity during pregnancy and antiviral effect of amniotic fluid | |
| Macri et al. | Prenatal diagnosis of neural tube defects | |
| Armenti et al. | Medical management of the pregnant transplant recipient | |
| Hogge et al. | Fetal evaluation by percutaneous blood sampling | |
| Hines et al. | Production of foetally stimulated lymphocytotoxic antibodies by multiparous cows | |
| Suresh et al. | Single second-trimester cervical length is predictive of preterm delivery among patients with prophylactic cerclage | |
| Golden | Reproductive histories in a Norwegian twin population: evaluation of the maternal effect in early spontaneous abortion | |
| Stewart et al. | AMNIOTIC FLUlD α1 FETOPROTEIN IN THE DIAGNOSIS OF NEURAL TRACT MALFORMATIONS | |
| Stabile et al. | Spontaneous abortion: diagnosis and treatment | |
| Vick et al. | Determination of normal human fetal immunoglobulin M levels | |
| Laxova et al. | A clinical service for prenatal diagnosis | |
| Bombard et al. | Prospective pilot evaluation of early (11–14 weeks' gestation) amniocentesis in 75 patients | |
| Craven et al. | Human Immunodeficiency Virus Infection in Pregnancy Epidemiology and Prevention of Vertical Transmission | |
| Brock | α-Fetoprotein and the Prenatal Diagnosis of Central Nervous System Disorders: A Review | |
| Ljung et al. | Hemophilia A and B—two years ex‐perience of genetic counselling and prenatal diagnosis | |
| Fairbrother et al. | The amniotic fluid foam test and fat cell count in malnourished and well‐nourished fetuses | |
| Whittle et al. | Amniotic fluid phosphatidylglycerol: an early indicator of fetal lung maturity | |
| Field et al. | Prenatal diagnosis and selective abortion for anencephaly and spina bifida | |
| Sybert et al. | Prenatal diagnosis and genetic screening for epidermolysis bullosa | |
| Wax et al. | Fetal blood sampling |